Keyphrases
COVID-19
73%
Population Immunity
29%
Treatment Outcome
17%
Hydroxychloroquine
17%
Clinical Presentation
16%
Isolated Cerebral mucormycosis
14%
Virus
14%
Mpox
14%
Vaccine Equity
14%
Testing Algorithm
14%
Antiretroviral Therapy
14%
Transmission Potential
14%
Living Systematic Review
14%
Clinical Treatment
14%
Mpox Virus
14%
American Health Care System
14%
Primary Cytomegalovirus Infection
14%
Congregate Settings
14%
Omicron Lineages
14%
City Health
14%
Pre-exposure Prophylaxis (PrEP)
14%
People Living with HIV (PLHIV)
14%
Hospitalized Patients
14%
Mycoplasma Genitalium
14%
Large Cohort
14%
Liver Biochemistry
14%
Screening Recommendations
14%
Cervical Lymphadenitis
14%
New York City
14%
Mogamulizumab
14%
Health Systems
14%
Viral Host Factor
14%
Racial Minorities
14%
Global Case
14%
2022 Outbreak
14%
Human Immunodeficiency Virus Testing
14%
Aspartate Aminotransferase
12%
Hybrid Immunity
8%
Prevention of Infective Endocarditis
7%
Alanine Aminotransferase
7%
Elevated Viral Load
7%
Pandemic Spread
7%
Respiratory Transmission
7%
HTLV-1-associated Myelopathy
6%
Azithromycin
6%
Moxifloxacin
6%
Course of Illness
5%
Hospitalization
5%
Clinical Trials
5%
Persistent Infection
5%
Medicine and Dentistry
COVID-19
77%
Infection
44%
Disease
30%
Systematic Review
29%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Symptom
21%
Infective Endocarditis
19%
Omicron Coronavirus Variant
17%
Men Who Have Sex with Men
14%
Aspartate Aminotransferase
14%
Virus Infection
14%
Patient with Tetralogy of Fallot
14%
Lymphadenitis
14%
Monkeypox
14%
Proctitis
14%
Mycobacterium Avium Complex
14%
Tocilizumab
14%
Disease Course
14%
Mycoplasma genitalium
14%
Human Immunodeficiency Virus
14%
Meta-Analysis
14%
Elderly Patient
14%
Endocarditis
14%
Antiviral Therapy
14%
Health Care
14%
Mogamulizumab
14%
Viral Host Factor
14%
Mucormycosis
14%
Placebo
12%
Azithromycin
11%
Alanine Aminotransferase
8%
Transaminase
8%
Subclinical Infection
8%
Complex Congenital Heart Disease
6%
Moxifloxacin
6%
Opiate
6%
Outpatient
5%
Liver Injury
5%
Intubation
5%
Drug Use
5%
Antivirus Agent
5%
Statin
5%
Immunomodulating Agent
5%
Persistent Infection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Coronavirinae
91%
HIV
29%
Infection
26%
Hydroxychloroquine
16%
Placebo
16%
Immunomodulation
14%
Antiviral Therapy
14%
Tocilizumab
14%
Vaccination Policy
14%
Mogamulizumab
14%
Monkeypox
14%
Mucormycosis
14%
Antivirus Agent
10%
Aspartate Aminotransferase
9%
SARS Coronavirus
8%
Tenofovir
7%
Syndrome
7%
Cytokine
7%
Human Immunodeficiency Virus Infection
7%
Symptom
5%
Randomized Controlled Trial
5%
Opiate
5%
Intubation
5%
Aminotransferase
5%
Alanine Aminotransferase
5%
Clinical Trial
5%